• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Epidemiology of atrial fibrillation.

作者信息

Conen David

机构信息

Associate Professor of Medicine McMaster University Population Health Research Institute St. Joseph's Healthcare Hamilton 50 Charlton Avenue East Hamilton ON L8N 4A6, Canada Tel: +1 905 521 2100 Ext 40690 Fax: +1 905-521-6068.

出版信息

Eur Heart J. 2018 Apr 21;39(16):1323-1324. doi: 10.1093/eurheartj/ehy171.

DOI:10.1093/eurheartj/ehy171
PMID:29688435
Abstract
摘要

相似文献

1
Epidemiology of atrial fibrillation.心房颤动的流行病学
Eur Heart J. 2018 Apr 21;39(16):1323-1324. doi: 10.1093/eurheartj/ehy171.
2
Epidemiology of atrial fibrillation in Spain in the past 20 years.西班牙过去20年心房颤动的流行病学。
Rev Esp Cardiol (Engl Ed). 2013 Jul;66(7):561-5. doi: 10.1016/j.rec.2013.02.012. Epub 2013 May 28.
3
[Epidemiology of paroxysmal auricular fibrillation].
Arch Mal Coeur Vaiss. 1998 Jan;91(1):67-71.
4
Atrial fibrillation and flutter after coronary artery bypass surgery: epidemiology, risk factors and preventive trials.
Int J Cardiol. 1992 Sep;36(3):253-61. doi: 10.1016/0167-5273(92)90293-c.
5
Atrial fibrillation: epidemiology and the risk and prevention of stroke.心房颤动：流行病学以及中风的风险与预防
Pacing Clin Electrophysiol. 1992 Sep;15(9):1332-46. doi: 10.1111/j.1540-8159.1992.tb03143.x.
6
[Epidemiology of the relationship between atrial fibrillation and heart failure].[心房颤动与心力衰竭关系的流行病学]
Pan Afr Med J. 2017 Mar 2;26:116. doi: 10.11604/pamj.2017.26.116.11470. eCollection 2017.
7
[Epidemiology, risk factors, and pathogeny of atrial fibrillation and atrial flutter].心房颤动与心房扑动的流行病学、危险因素及发病机制
Rev Esp Cardiol. 1996;49 Suppl 2:1-7.
8
Epidemiology of new-onset paroxysmal atrial fibrillation in the General Intensive Care Unit population and after discharge from ICU. A retrospective epidemiological study.综合重症监护病房人群中新发阵发性心房颤动的流行病学及重症监护病房出院后的情况。一项回顾性流行病学研究。
Anaesthesiol Intensive Ther. 2015;47(4):309-14. doi: 10.5603/AIT.a2015.0040. Epub 2015 Jul 26.
9
The atrial fibrillation ablation pilot study: a European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association.心房颤动消融先导研究：一项由欧洲心律协会开展的关于导管消融治疗心房颤动的方法学和结果的欧洲调查。
Eur Heart J. 2014 Jun 7;35(22):1466-78. doi: 10.1093/eurheartj/ehu001. Epub 2014 Jan 31.
10
Recent progress in the epidemiology of atrial fibrillation.心房颤动流行病学的最新进展。
Curr Opin Cardiol. 2005 Jan;20(1):7-14.

引用本文的文献

1
Recent advances in the tools and techniques for AI-aided diagnosis of atrial fibrillation.人工智能辅助心房颤动诊断工具与技术的最新进展。
Biophys Rev (Melville). 2025 Jan 15;6(1):011301. doi: 10.1063/5.0217416. eCollection 2025 Mar.
2
Effect of Obesity on the Use of Antiarrhythmics in Adults With Atrial Fibrillation: A Narrative Review.肥胖对心房颤动成人抗心律失常药物使用的影响：叙述性综述。
Clin Cardiol. 2024 Aug;47(8):e24336. doi: 10.1002/clc.24336.
3
Early Echocardiographic Predictors for Atrial Fibrillation Propensity: The Left Atrium Oracle.
心房颤动倾向的早期超声心动图预测指标：左心房预测模型
Rev Cardiovasc Med. 2022 May 31;23(6):205. doi: 10.31083/j.rcm2306205. eCollection 2022 Jun.
4
Evolving Trends in Consumption of Direct Oral Anticoagulants in 65 Countries/Regions from 2008 to 2019.2008年至2019年65个国家/地区直接口服抗凝剂的消费演变趋势
Drugs. 2023 Mar;83(4):315-340. doi: 10.1007/s40265-023-01837-0. Epub 2023 Feb 25.
5
Construction of a Clinical Predictive Model of Left Atrial and Left Atrial Appendage Thrombi in Patients with Nonvalvular Atrial Fibrillation.构建非瓣膜性心房颤动患者左心房和左心耳血栓的临床预测模型。
J Interv Cardiol. 2022 Nov 4;2022:7806027. doi: 10.1155/2022/7806027. eCollection 2022.
6
Identification of Atrial Fibrillation-Related lncRNA Based on Bioinformatic Analysis.基于生物信息学分析的房颤相关 lncRNA 的鉴定。
Dis Markers. 2022 Feb 4;2022:8307975. doi: 10.1155/2022/8307975. eCollection 2022.
7
Peptide Inhibitors of Kv1.5: An Option for the Treatment of Atrial Fibrillation.Kv1.5的肽类抑制剂：一种治疗心房颤动的选择。
Pharmaceuticals (Basel). 2021 Dec 14;14(12):1303. doi: 10.3390/ph14121303.
8
Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study.非瓣膜性心房颤动患者口服抗凝治疗中持续性模式的预测因素、时间进程和结局：一项荷兰全国队列研究。
Eur Heart J. 2021 Oct 21;42(40):4126-4137. doi: 10.1093/eurheartj/ehab421.
9
Exosomes in atrial fibrillation: therapeutic potential and role as clinical biomarkers.心房颤动中的外泌体：治疗潜力及作为临床生物标志物的作用
Heart Fail Rev. 2022 Jul;27(4):1211-1221. doi: 10.1007/s10741-021-10142-5. Epub 2021 Jul 12.
10
Modifiable Risk Factors and Atrial Fibrillation: the Quest for a Personalized Approach.可改变的风险因素与心房颤动：寻求个性化方法
Maedica (Bucur). 2021 Mar;16(1):88-96. doi: 10.26574/maedica.2020.16.1.88.